Evaluation of Adult Urine Testing/Drug Use Surveillance Project in Washington, DC, 1984-1986

These data were gathered to assess whether drug users are greater risks than nonusers for rearrest or failure to appear for scheduled court appearances while on pretrial release. The data also evaluate the relative effectiveness of periodic surveillance through urinalysis, traditional narcotic treatment, or neither in reducing rearrest and failure to appear during the pretrial period. The collection provides information on arrestees who both tested positive for drugs and were released on recognizance as well as those arrestees who tested negative but were not released on recognizance. Drugs tested for include heroin, cocaine, PCP, methadone, and amphetamines. Arrestees who were released were randomly assigned to one of three groups: weekly urine testing, referral to drug treatment, or a control condition. The data offer information on the offender's background, family and employment status, probation and parole status, pending charges, and prior convictions. Other variables include date of arrest, charge, initial release, decision, date of disposition, type of final disposition, number of subsequent arrests before trial, and number of bench warrants issued. Results of urine tests at arrest are available for about 65 percent of the total sample. For those in the experimental surveillance group, summary urine test results from the periodic testing program are available. There is no measure of treatment for the drug treatment or control groups.

Data e Risorse

Campo Valore
accessLevel public
bureauCode {011:21}
catalog_@context https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld
catalog_@id https://www.justice.gov/data.json
catalog_conformsTo https://project-open-data.cio.gov/v1.1/schema
catalog_describedBy https://project-open-data.cio.gov/v1.1/schema/catalog.json
datagov_dedupe_retained 20210820010620
identifier 3440
issued 1993-05-13T00:00:00
language {eng}
license http://www.usa.gov/publicdomain/label/1.0/
modified 1993-05-13T00:00:00
programCode {011:060}
publisher National Institute of Justice
publisher_hierarchy Office of Justice Programs > National Institute of Justice
resource-type Dataset
source_datajson_identifier true
source_hash cb66ec1da289c0860274236c5697f8ffc12b841d
source_schema_version 1.1
Gruppi
  • AmeriGEOSS
  • National Provider
  • North America
Tag
  • amerigeo
  • amerigeoss
  • ckan
  • drug-testing
  • drug-treatment
  • drug-use
  • geo
  • geoss
  • national
  • north-america
  • pretrial-procedures
  • recidivism
  • substance-abuse
  • united-states
  • urinalysis
isopen False
license_id us-pd
license_title us-pd
maintainer Open Data Office of Justice Programs (USDOJ)
maintainer_email opendata@usdoj.gov
metadata_created 2025-11-21T03:22:48.218576
metadata_modified 2025-11-21T03:22:48.218580
notes These data were gathered to assess whether drug users are greater risks than nonusers for rearrest or failure to appear for scheduled court appearances while on pretrial release. The data also evaluate the relative effectiveness of periodic surveillance through urinalysis, traditional narcotic treatment, or neither in reducing rearrest and failure to appear during the pretrial period. The collection provides information on arrestees who both tested positive for drugs and were released on recognizance as well as those arrestees who tested negative but were not released on recognizance. Drugs tested for include heroin, cocaine, PCP, methadone, and amphetamines. Arrestees who were released were randomly assigned to one of three groups: weekly urine testing, referral to drug treatment, or a control condition. The data offer information on the offender's background, family and employment status, probation and parole status, pending charges, and prior convictions. Other variables include date of arrest, charge, initial release, decision, date of disposition, type of final disposition, number of subsequent arrests before trial, and number of bench warrants issued. Results of urine tests at arrest are available for about 65 percent of the total sample. For those in the experimental surveillance group, summary urine test results from the periodic testing program are available. There is no measure of treatment for the drug treatment or control groups.
num_resources 1
num_tags 15
title Evaluation of Adult Urine Testing/Drug Use Surveillance Project in Washington, DC, 1984-1986